Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) wishes to announce that further to its news release on September 26, 2018, the Company has closed over-subscribed on the non-brokered unsecured debenture financing through the issuance of CDN$3,263,093 principal number of debentures.

The Debentures mature on October 23, 2019 and bear interest at a rate of 10% per annum, which shall accrue and be paid on the maturity date. The Debentures shall be convertible into units of the Company at a conversion of $0.20 per Debenture Unit. Each unit will be comprised of one Common Share of the Company and one Common Share Purchase Warrant exercisable at $0.50 for one year from the date of issuance.

In connection with the Debenture Offering, the Company paid cash finder’s fees of $132,986 and issued 48,216 finder’s warrants exercisable at $0.50 for one year from the date of issuance.

All securities issued in connection with the Debenture Offering will be subject to a four-month hold period from the date of issue under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.

One Year Warrant Extension

The Company has extended the term of 3,443,900 common share purchase Warrants issued as part of a brokered private placement which closed on January 24, 2018. Each of the Warrants, which were part of the units being issued, entitles its holder to purchase one common share of Marapharm Ventures Inc. at an exercise price of $1.25c per Common Share until January 31, 2019. Marapharm has elected to extend the expiry date of the Warrants to January 31, 2020. No other Warrant terms are amended.

ABOUT MARAPHARM VENTURES INC.

Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.